These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 4467051)

  • 1. [Peritoneal permeability to plasma proteins during peritoneal dialysis].
    Scarpioni L; Dall'Aglio P; Orlandini G; Petrella E; Poisetti G
    Minerva Nefrol; 1974; 21(4):294-8. PubMed ID: 4467051
    [No Abstract]   [Full Text] [Related]  

  • 2. [Peritoneum as a dialysis membrane. II. Pathology].
    Grzybowski A; Breborowicz A
    Przegl Lek; 1997; 54(1):52-61. PubMed ID: 9190636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is new in peritoneal dialysis in the years 2003-2004.
    Grzegorzewska AE
    Rocz Akad Med Bialymst; 2004; 49():170-3. PubMed ID: 15631336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and ultrastructural peritoneal membrane changes and permeability alterations during continuous ambulatory peritoneal dialysis.
    Verger C; Brunschvicg O; Le Charpentier Y; Lavergne A; Vantelon J
    Proc Eur Dial Transplant Assoc; 1981; 18():199-205. PubMed ID: 7329968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Protein balance in patients treated with intermittent peritoneal dialysis].
    Radovanović L; Lazić N; Dukanović L; Radlović O; Radmilović A; Dragicević P; Busarac D; Ikonomovski J; Vidanović M; Rosić D
    Lijec Vjesn; 1982; 104(11-12):530-1. PubMed ID: 7187481
    [No Abstract]   [Full Text] [Related]  

  • 6. [Automated peritoneal dialysis: impact on residual kidney function and peritoneal membrane permeability].
    Gallar P; Ortega O; Gutiérrez M; Carreño A; Domínguez-Gil B; Hilara L; Oliet A; Rodríguez I; Giménez E; Vigil A
    Nefrologia; 2001; 21(2):200-3. PubMed ID: 11464654
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prevention of malnutrition in peritoneal dialysis patients].
    Lobbedez T; Pujo M; el Haggan W; Hurault de Ligny B; Levaltier B; Ryckelynck JP
    Nephrologie; 2003; 24(7):387-9. PubMed ID: 14650752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. For how long can peritoneal dialysis be continued?
    Oreopoulos DG; Gotloib L; Calderaro V; Khanna R
    Can Med Assoc J; 1981 Jan; 124(1):12-4. PubMed ID: 7459766
    [No Abstract]   [Full Text] [Related]  

  • 9. What are the problems with using the peritoneal membrane for long-term dialysis?
    Bargman JM; Krediet RT; Lo WK; Selgas R; del Peso G; Auxiliadora Bajo M; Mujais S
    Semin Dial; 2008; 21(1):11-23. PubMed ID: 18251949
    [No Abstract]   [Full Text] [Related]  

  • 10. Peritoneal membrane structural and functional changes during peritoneal dialysis.
    Goffin E
    Semin Dial; 2008; 21(3):258-65. PubMed ID: 18363601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of various pharmacological and conventional methods of increasing the effectiveness of peritoneal dialysis. I. Intraperitoneal or intravenous use of furosemide during intermittent peritoneal dialysis].
    Grzegorzewska A
    Przegl Lek; 1988; 45(4):365-73. PubMed ID: 3212200
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of drugs on peritoneal dialysis clearance].
    Djukanović Lj; Ikonomovski J; Milovanović D
    Srp Arh Celok Lek; 1984 Jan; 112(1):115-26. PubMed ID: 6505849
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparison of various pharmacological and conventional methods of increasing the effectiveness of peritoneal dialysis. II. Intraperitoneal administration of sodium nitroprusside during intermittent peritoneal dialysis].
    Grzegorzewska A
    Przegl Lek; 1988; 45(6):485-90. PubMed ID: 3252349
    [No Abstract]   [Full Text] [Related]  

  • 14. Increased peritoneal solute transport in diabetic peritoneal dialysis patients.
    Lin JJ; Wadhwa NK; Suh H; Cabralda T; Patlak CS
    Adv Perit Dial; 1995; 11():63-6. PubMed ID: 8534740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and metabolic aspects of chronic peritoneal dialysis.
    Andersen KE
    Scand J Urol Nephrol Suppl; 1983; 74():1-105. PubMed ID: 6364335
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationship between dialysate oxidized protein and peritoneal membrane transport properties in patients on peritoneal dialysis.
    Latcha S; Hong S; Gibbons N; Kohn N; Mattana J
    Nephrol Dial Transplant; 2008 Oct; 23(10):3295-301. PubMed ID: 18443211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peritoneal protein losses in diabetic patients starting peritoneal dialysis: is there a relationship with diabetic vascular lesions?
    Coronel F; Cigarrán S; Herrero JA; Delgado J; Ramos F; Gomis A
    Adv Perit Dial; 2009; 25():115-8. PubMed ID: 19886331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dialysate CA125 levels in stable peritoneal dialysis patients.
    Okada T; Nakao T; Matsumoto H
    Clin Nephrol; 1999 Jan; 51(1):65-6. PubMed ID: 9988153
    [No Abstract]   [Full Text] [Related]  

  • 19. [Determination of substances of middle molecular mass in the body fluids of patients treated with intermittent peritoneal dialysis].
    Dukanović L; Petrović J
    Lijec Vjesn; 1982; 104(11-12):527-9. PubMed ID: 7187480
    [No Abstract]   [Full Text] [Related]  

  • 20. Outcome for continuous ambulatory peritoneal dialysis patients is not predicted by peritoneal permeability characteristics.
    Passadakis PS; Thodis ED; Panagoutsos SA; Selisiou CA; Pitta EM; Vargemezis VA
    Adv Perit Dial; 2000; 16():2-6. PubMed ID: 11045251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.